Susan Wong

2.2k citations

39 papers · 833 indexed · h-index 17

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 19
- Drug-Induced Hepatotoxicity and Protection 5
Oncology top 10%
- Drug Transport and Resistance Mechanisms 12
Transplantation
Nutrition and Dietetics top 10%
Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems 3
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 6
Molecular Biology
- Biochemical and Molecular Research 4
- PI3K/AKT/mTOR signaling in cancer 3
Genetics
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Kerin O’Dea Jason Halladay Jane R. Kenny Vincent J. Wacher S. Cyrus Khojasteh Lisa M. Almond I. Gardner Masoud Jamei
Cited by: Pharmacology Oncology Transplantation
Journals: Analytical Chemistry (1 paper)American Journal of Clinical Nutrition (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Susan Wong

38 papers receiving 761 citations

Peers

Countries citing papers authored by Susan Wong

Since Specialization

Citations

This map shows the geographic impact of Susan Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Wong more than expected).

Fields of papers citing papers by Susan Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Wong. The network helps show where Susan Wong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan Wong Line = papers co-authored together Susan Wong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP1 Nuclear Medicine and Biology ·Jan Mařı́k,S. Rich,Gauri Deshmukh,Donglu Zhang,Jeff N. Tinianow,Jingwei Cai,Susan Wong,Sudheer Bobba,Kevin DeMent,Ning Liu,Jason Halladay,Sandra Sanabria Bohórquez,Lionel Cheruzel,S. Cyrus Khojasteh	2023	1
2	An Integrated Strategy for Assessing the Metabolic Stability and Biotransformation of Macrocyclic Peptides in Drug Discovery toward Oral Delivery Analytical Chemistry ·Yukuang Guo,Shaofei Ji,Wei Wang,Susan Wong,Chun‐Wan Yen,Chloe Hu,Dennis Leung,Emile G. Plise,Shu Zhang,Chenghong Zhang,Uchenna A. Anene,Donglu Zhang,Christian N. Cunningham,S. Cyrus Khojasteh,Dian Su	2022	13
3	Investigating the Utility of Humanized Pregnane X Receptor-Constitutive Androstane Receptor-CYP3A4/7 Mouse Model to Assess CYP3A-Mediated Induction Drug Metabolism and Disposition ·Justin Q. Ly,Susan Wong,Liling Liu,Ruina Li,Kirsten Messick,Jae H. Chang	2021	3
4	Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug‐Drug Interactions? Preclinical and Clinical Studies With 13‐cis‐Retinoic Acid Clinical and Translational Science ·Faith Stevison,Mika Kosaka,Jane R. Kenny,Susan Wong,Cathryn A. Hogarth,John K. Amory,Nina Isoherranen	2019	22
5	Applying Stable Isotope Labeled Amino Acids in Micropatterned Hepatocyte Coculture to Directly Determine the Degradation Rate Constant for CYP3A4 Drug Metabolism and Disposition ·Ryan Takahashi,Sheerin Shahidi-Latham,Susan Wong,Jae H. Chang	2017	13
6	Strategy for CYP3A Induction Risk Assessment from Preclinical Signal to Human: a Case Example of a Late-Stage Discovery Compound Pharmaceutical Research ·Jialin Mao,Peter W. Fan,Susan Wong,Jianshuang Wang,Moulay Hicham Alaoui Ismaili,Brian Dean,Cornelis E. C. A. Hop,Matthew Wright,Yuan Chen	2017	3
7	Characterizing thein vitrospecies differences in N-glucuronidation of a potent pan-PIM inhibitor GNE-924 containing a 3,5-substituted 6-azaindazole Xenobiotica ·Molly Lin,Justin Q. Ly,Ryan Takahashi,John Chen,Alan Deese,Sarah J. Robinson,Aleksandr Kolesnikov,Susan Wong,Xiaojing Wang,Jae H. Chang	2017	0
8	Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model Drug Metabolism and Disposition ·Lisa M. Almond,Sophie Mukadam,I. Gardner,K. Okialda,Susan Wong,Oliver Hatley,Sun Tee Tay,K Rowland‐Yeo,Masoud Jamei,Amin Rostami‐Hodjegan,Jane R. Kenny	2016	91
9	A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease–Drug Interactions: Suppression of CYP3A by IL-6 Clinical Pharmacology & Therapeutics ·Krishna K. Machavaram,Lisa M. Almond,Amin Rostami‐Hodjegan,I. Gardner,Masoud Jamei,Suzanne Tay,Susan Wong,Amita Joshi,Jane R. Kenny	2013	86
10	Comparison of In Vitro-In Vivo Extrapolation of Biliary Clearance Using an Empirical Scaling Factor Versus Transport-Based Scaling Factors in Sandwich-Cultured Rat Hepatocytes Journal of Pharmaceutical Sciences ·Peng Zou,Xingrong Liu,Susan Wong,Meihua Rose Feng,Bianca M. Liederer	2013	16
11	An ‘all-inclusive’ 96-well cytochrome P450 induction method: Measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes Journal of Pharmacological and Toxicological Methods ·Jason Halladay,Susan Wong,S. Cyrus Khojasteh,Susan Grepper	2012	27
12	Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human Drug Metabolism and Disposition ·Laurent Salphati,Jodie Pang,Emile G. Plise,Leslie B. Lee,Alan G. Olivero,Wei Wei Prior,Deepak Sampath,Susan Wong,Xiaolin Zhang	2012	30
13	Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human Xenobiotica ·Laurent Salphati,Jodie Pang,Emile G. Plise,Bilin Chou,Jason Halladay,Alan G. Olivero,Patrick J. Rudewicz,Qingping Tian,Susan Wong,Xiaolin Zhang	2011	20
14	Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor Xenobiotica ·Harvey Wong,J.Z. Chen,Bilin Chou,Jason Halladay,Jane R. Kenny,Hanson La,James C. Marsters,Emile G. Plise,Patrick J. Rudewicz,Kirk Robarge,Young G. Shin,Susan Wong,Chen Zhang,S. Cyrus Khojasteh	2009	47
15	Metabolic Stability Screen for Drug Discovery Using Cassette Analysis and Column Switching Drug Metabolism Letters ·Jason Halladay,Susan Wong,Sharmin Jaffer,Achintya Sinhababu,S. Cyrus Khojasteh-Bakht	2007	20
16	Peppermint Oil Enhances Cyclosporine Oral Bioavailability in Rats: Comparison with d‐α‐Tocopheryl Poly(ethylene glycol 1000) Succinate (TPGS) and Ketoconazole Journal of Pharmaceutical Sciences ·Vincent J. Wacher,Susan Wong,Harrison T. Wong	2002	41
17	Sirolimus Oral Absorption in Rats Is Increased by Ketoconazole but Is Not Affected by d-α-Tocopheryl Poly(Ethylene Glycol 1000) Succinate Journal of Pharmacology and Experimental Therapeutics ·Vincent J. Wacher,Jeffrey A. Silverman,Susan Wong,Paulina Tran-Tau,Amy O. Chan,Anne Chai,Xiang‐Qing Yu,Daniel J. O’Mahony,Zebunnissa Ramtoola	2002	16
18	Minimal effect of ketoconazole on cyclosporine (SangCyA^TM) oral absorption and first‐pass metabolism in rats: evidence of a significant vehicle effect on SangCyA absorption Biopharmaceutics & Drug Disposition ·Susan Wong,Harrison T. Wong,Vincent J. Wacher	2002	5
19	Factors affecting the rate of hydrolysis of starch in legumes American Journal of Clinical Nutrition ·Susan Wong,Kathy Traianedes,Kerin O’Dea	1985	36
20	The rate of starch hydrolysis in vitro does not predict the metabolic responses to legumes in vivo American Journal of Clinical Nutrition ·Kerin O’Dea,Susan Wong	1983	25

About Susan Wong

Susan Wong is a scholar working on Pharmacology, Pharmaceutical Science and Oncology, having authored 39 papers that have together received 833 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Biochemical and Molecular Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Drug Solubulity and Delivery Systems (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Pharmacology (314 citations), Oncology (248 citations) and Transplantation (18 citations). Susan Wong has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Kerin O’Dea, Jason Halladay, Jane R. Kenny, Vincent J. Wacher, S. Cyrus Khojasteh, Lisa M. Almond, I. Gardner, Masoud Jamei, Amin Rostami‐Hodjegan and Emile G. Plise. Their work appears in journals such as Analytical Chemistry, American Journal of Clinical Nutrition and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact